Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soliqua Titration Strategies in T2DM
NCT03767543Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2019
- Primary completion
- Oct 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine + lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Mar 2019; status: completed.
02
Drugs
insulin glargine + lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03767543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03767543.